Synthetic methods of making (2H-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators
US-12570658-B2 · Mar 10, 2026 · US
non-acylated
non-acylated · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D295/30 |
| Official title | non-acylated |
| Display label | non-acylated |
| Total patents | 33 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 9 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Phenoxy-acetyl-thioureido-benzenesulfonamide derivatives, and their uses
US-2024391872-A1 · Nov 28, 2024 · US
Bench-stable triazene compositions for protein modification
US-2024277847-A1 · Aug 22, 2024 · US
Improved synthetic methods of making (2h-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators
US-2022289754-A1 · Sep 15, 2022 · US
Autotaxin inhibitors
US-11124490-B2 · Sep 21, 2021 · US
Autotaxin inhibitors
US-2020317626-A1 · Oct 8, 2020 · US
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
US-10597381-B2 · Mar 24, 2020 · US
Bis-diazeniumdiolate compounds as anti-cancer agents
US-10556875-B2 · Feb 11, 2020 · US
Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance
US-10329247-B2 · Jun 25, 2019 · US
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
US-2019135782-A1 · May 9, 2019 · US
Bis-diazeniumdiolate compounds as anti-cancer agents
US-2019106396-A1 · Apr 11, 2019 · US
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
US-10233171-B2 · Mar 19, 2019 · US
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US-2018251426-A1 · Sep 6, 2018 · US
Novel antiviral agents against hbv infection
US-2018230092-A1 · Aug 16, 2018 · US
Antiviral agents against HBV infection
US-9938236-B2 · Apr 10, 2018 · US
Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance
US-2017349539-A1 · Dec 7, 2017 · US
Amyloid binding agents
US-2017315137-A1 · Nov 2, 2017 · US
Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance
US-9776954-B2 · Oct 3, 2017 · US
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
US-2017233370-A1 · Aug 17, 2017 · US
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
US-9580398-B2 · Feb 28, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D295/30?
- CPC C07D295/30 is the Cooperative Patent Classification code for “non-acylated.”
- How many patents are filed under CPC C07D295/30 (non-acylated)?
- Our database includes 33 publications tagged with this CPC code.
- Is patent activity under CPC C07D295/30 growing?
- Publication counts under this code: 1 in 2022 vs 2 in 2024 (latest complete years).